Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

ALLR Allarity Therapeutics Inc

Price (delayed)

$0.87

Market cap

$13.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.58

Enterprise value

-$13.22M

Highlights
Allarity Therapeutics's EPS has surged by 100% YoY and by 90% QoQ
ALLR's equity has soared by 58% from the previous quarter
Allarity Therapeutics's net income has shrunk by 89% YoY but it has increased by 4.5% QoQ

Key stats

What are the main financial stats of ALLR
Market
Shares outstanding
15.08M
Market cap
$13.12M
Enterprise value
-$13.22M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.79
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$26.04M
Net income
-$23.4M
EBIT
-$23.17M
EBITDA
-$23.16M
Free cash flow
-$18.55M
Per share
EPS
-$1.58
EPS diluted
-$1.58
Free cash flow per share
-$1.66
Book value per share
$1.1
Revenue per share
$0
TBVPS
$2.67
Balance sheet
Total assets
$29.73M
Total liabilities
$11.06M
Debt
$1.36M
Equity
$18.67M
Working capital
$18.36M
Liquidity
Debt to equity
0.07
Current ratio
2.66
Quick ratio
2.5
Net debt/EBITDA
1.14
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-92.7%
Return on equity
-151.7%
Return on invested capital
N/A
Return on capital employed
-124.1%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ALLR stock price

How has the Allarity Therapeutics stock price performed over time
Intraday
-1.02%
1 week
-6.24%
1 month
-21.62%
1 year
-95.13%
YTD
-25.64%
QTD
-7.14%

Financial performance

How have Allarity Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$26.04M
Net income
-$23.4M
Gross margin
N/A
Net margin
N/A

ALLR financials

Allarity Therapeutics's net income has shrunk by 89% YoY but it has increased by 4.5% QoQ
ALLR's operating income is down by 47% year-on-year but it is up by 4.4% since the previous quarter

Price vs fundamentals

How does ALLR's price correlate with its fundamentals

ALLR Price vs fundamentals

ALLR Earnings waterfall

ALLR Price vs fair value

Growth

What is Allarity Therapeutics's growth rate over time

ALLR growth chart

Valuation

What is Allarity Therapeutics stock price valuation
P/E
N/A
P/B
0.79
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A

Valuation vs average

Price to earnings (P/E)

Allarity Therapeutics's EPS has surged by 100% YoY and by 90% QoQ

Price to book (P/B)

ALLR's P/B is 98% above its last 4 quarters average of 0.4
ALLR's equity has soared by 58% from the previous quarter

Price to sales (P/S)

Efficiency

How efficient is Allarity Therapeutics business performance
Allarity Therapeutics's ROA has increased by 43% YoY and by 21% from the previous quarter
ALLR's ROE is up by 42% QoQ

Dividends

What is ALLR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALLR.

Financial health

How did Allarity Therapeutics financials performed over time

Assets vs liabilities

ALLR's total assets is 169% more than its total liabilities
ALLR's total assets has soared by 148% YoY and by 31% from the previous quarter
Allarity Therapeutics's total liabilities has decreased by 40% YoY but it has increased by 2% from the previous quarter

Debt vs equity

The company's debt is 93% lower than its equity
ALLR's debt to equity has surged by 117% year-on-year but it is down by 36% since the previous quarter
ALLR's equity has soared by 58% from the previous quarter

Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.